News Release

10/01/2013
Release
Notice for Exercise of the 36th Round of Stock Options in September, 2013
09/06/2013
Release
Notice for Patent Grant in Canada and India
09/02/2013
Release
Notice for Exercise of the 36th Round of Stock Options in August, 2013
08/30/2013
Release
Notice of New Executive Officer
08/01/2013
Release
Notice for Exercise of the 36th Round of Stock Options in July, 2013
08/01/2013
Release
Notice of Establishment of an Affiliate Company (middle holding company)
07/01/2013
Release
Notice for Exercise of the 36th Round of Stock Options in June, 2013
07/01/2013
Release
Notice of Concluding LOI regarding Establishment of an Affiliate Company (middle holding company)
07/01/2013
Release
Notice of Changing Representative
06/28/2013
Release
Completion of F351 Ib clinical trials and receiving manufacture method patent approval for F351 in China.
06/10/2013
Release
Notice of Payment for the 36th Round of Stock Options
06/07/2013
Release
Receipt of Grant Notice and Record of Non-Operation Income at Shanghai Genomics Inc.
06/04/2013
Release
Conclusion of the Contract for Acceptance of Investment from Third Party Into Beijing Continent
05/30/2013
Event Calendar
CHI Bio-IT World Asia
05/22/2013
Release
GNI Announces Third-Party Allotment and the Issuance of the 36th Round of Stock Options with Moving Strike